Clinical Trials

Showing trials with last updates posted in 2023.

NCT04409314 | COMPLETED
23 participants

Hypoxia-Specific Imaging to Predict Outcomes of Chimeric Antigen Receptor T-cell Therapy

Study Type:
OBSERVATIONAL
Last Updated:
2023-08-21
Start Date:
2020-04-16
Completion:
2023-08-09
Conditions
  • Recurrent Aggressive Non-Hodgkin Lymphoma
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Recurrent High Grade B-Cell Lymphoma
  • Recurrent Malignant Neoplasm
  • Recurrent Plasma Cell Myeloma
  • Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma
  • Refractory Aggressive Non-Hodgkin Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma
  • Refractory High Grade B-Cell Lymphoma
  • Refractory Malignant Neoplasm
  • Refractory Plasma Cell Myeloma
  • Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma
Interventions
  • DRUG
  • PROCEDURE
No Results Yet
NCT04029038 | WITHDRAWN | PHASE1/PHASE2
0 participants

Modified Immune Cells (CD19-CD22 CAR T Cells) in Treating Patients With Recurrent or Refractory CD19 Positive, CD22 Positive Leukemia or Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2023-08-21
Start Date:
2019-05-15
Completion:
2022-11-16
Conditions
  • CD19 Positive
  • CD22 Positive
  • Minimal Residual Disease
  • Progressive Disease
  • Recurrent B Acute Lymphoblastic Leukemia
  • Recurrent Chronic Lymphocytic Leukemia
  • Recurrent Non-Hodgkin Lymphoma
  • Refractory B Acute Lymphoblastic Leukemia
  • Refractory Chronic Lymphocytic Leukemia
  • Refractory Non-Hodgkin Lymphoma
Interventions
  • BIOLOGICAL
  • DRUG
No Results Yet
NCT03770130 | COMPLETED | EARLY_PHASE1
330 participants

Dexmedetomidine and Liver Transplantation

Study Type:
INTERVENTIONAL
Last Updated:
2023-08-21
Start Date:
2019-01-14
Completion:
2022-10-31
Conditions
  • Dexmedetomidine, Liver Transplantation, Allograft Function, Survival
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page